These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34009468)

  • 1. Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease.
    von Vietinghoff S; Kurts C
    Cell Tissue Res; 2021 Aug; 385(2):335-344. PubMed ID: 34009468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?
    Zhuang Q; Cheng K; Ming Y
    Curr Gene Ther; 2017; 17(6):442-452. PubMed ID: 29446734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction.
    Roy-Chowdhury E; Brauns N; Helmke A; Nordlohne J; Bräsen JH; Schmitz J; Volkmann J; Fleig SV; Kusche-Vihrog K; Haller H; von Vietinghoff S
    Cardiovasc Res; 2021 May; 117(6):1510-1522. PubMed ID: 32717023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
    Cormican S; Griffin MD
    Front Immunol; 2021; 12():664202. PubMed ID: 34163473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the CX
    Hamdan D; Robinson LA
    Am J Physiol Renal Physiol; 2021 Aug; 321(2):F121-F134. PubMed ID: 34121453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis.
    Wojdasiewicz P; Poniatowski LA; Kotela A; Deszczyński J; Kotela I; Szukiewicz D
    Arch Immunol Ther Exp (Warsz); 2014 Oct; 62(5):395-403. PubMed ID: 24556958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the fractalkine-CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes.
    Kuboi Y; Nishimura M; Ikeda W; Nakatani T; Seki Y; Yamaura Y; Ogawa K; Hamaguchi A; Muramoto K; Mizuno K; Ogasawara H; Yamauchi T; Yasuda N; Onodera H; Imai T
    Int Immunol; 2019 Apr; 31(5):287-302. PubMed ID: 30668715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The miR-561-5p/CX
    Chen EB; Zhou ZJ; Xiao K; Zhu GQ; Yang Y; Wang B; Zhou SL; Chen Q; Yin D; Wang Z; Shi YH; Gao DM; Chen J; Zhao Y; Wu WZ; Fan J; Zhou J; Dai Z
    Theranostics; 2019; 9(16):4779-4794. PubMed ID: 31367257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1 antitrypsin inhibits fractalkine-mediated monocyte-lung endothelial cell interactions.
    Mikosz A; Ni K; Gally F; Pratte KA; Winfree S; Lin Q; Echelman I; Wetmore B; Cao D; Justice MJ; Sandhaus RA; Maier L; Strange C; Bowler RP; Petrache I; Serban KA
    Am J Physiol Lung Cell Mol Physiol; 2023 Dec; 325(6):L711-L725. PubMed ID: 37814796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CX3CL1-CX3CR1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis.
    Helmke A; Nordlohne J; Balzer MS; Dong L; Rong S; Hiss M; Shushakova N; Haller H; von Vietinghoff S
    Kidney Int; 2019 Jun; 95(6):1405-1417. PubMed ID: 30948201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The deficiency of CX3CL1/CX3CR1 system ameliorates high fructose diet-induced kidney injury by regulating NF-κB pathways in CX3CR1-knock out mice.
    Yu YW; Li MX; Zhang ZY; Yu H
    Int J Mol Med; 2018 Jun; 41(6):3577-3585. PubMed ID: 29568873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.
    Green SR; Han KH; Chen Y; Almazan F; Charo IF; Miller YI; Quehenberger O
    J Immunol; 2006 Jun; 176(12):7412-20. PubMed ID: 16751386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.
    Poniatowski ŁA; Wojdasiewicz P; Krawczyk M; Szukiewicz D; Gasik R; Kubaszewski Ł; Kurkowska-Jastrzębska I
    Mol Neurobiol; 2017 Apr; 54(3):2167-2188. PubMed ID: 26927660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CX3CL1 deficiency ameliorates inflammation, apoptosis and accelerates osteogenic differentiation, mineralization in LPS-treated MC3T3-E1 cells via its receptor CX3CR1.
    Lu Z; Zhang A; Dai Y
    Ann Anat; 2023 Feb; 246():152036. PubMed ID: 36436718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CX3CL1-CX3CR1 Interaction Increases the Population of Ly6C(-)CX3CR1(hi) Macrophages Contributing to Unilateral Ureteral Obstruction-Induced Fibrosis.
    Peng X; Zhang J; Xiao Z; Dong Y; Du J
    J Immunol; 2015 Sep; 195(6):2797-805. PubMed ID: 26254342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CX3CR1/CX3CL1 Axis Mediates Platelet-Leukocyte Adhesion to Arterial Endothelium in Younger Patients with a History of Idiopathic Deep Vein Thrombosis.
    Furio E; García-Fuster MJ; Redon J; Marques P; Ortega R; Sanz MJ; Piqueras L
    Thromb Haemost; 2018 Mar; 118(3):562-571. PubMed ID: 29433150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression.
    Pachot A; Cazalis MA; Venet F; Turrel F; Faudot C; Voirin N; Diasparra J; Bourgoin N; Poitevin F; Mougin B; Lepape A; Monneret G
    J Immunol; 2008 May; 180(9):6421-9. PubMed ID: 18424766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine Suppresses Leukocyte Adherence by Downregulating CX3CL1 Expression and Shedding and ADAM10 in Lipopolysaccharide-Stimulated Vascular Endothelial Cells.
    Wu YH; Wei CY; Hong WC; Pang JS
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CX₃CL1 (fractalkine) and its receptor CX₃CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin.
    Staumont-Sallé D; Fleury S; Lazzari A; Molendi-Coste O; Hornez N; Lavogiez C; Kanda A; Wartelle J; Fries A; Pennino D; Mionnet C; Prawitt J; Bouchaert E; Delaporte E; Glaichenhaus N; Staels B; Julia V; Dombrowicz D
    J Exp Med; 2014 Jun; 211(6):1185-96. PubMed ID: 24821910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-edged sword: interactions of CX
    Estaleen RA; Reilly CM; Luo XM
    Front Immunol; 2023; 14():1330500. PubMed ID: 38299151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.